Crescent Pharma Limited

Active status, founded 23 years ago, 68 employees, revenue range: 54m+, virtual address, 3 directors, 1 owner, located in Basingstoke. Regular importer of various medicines not listed elsewhere, small plastic bottles (under 2 liters), liquid chemical products at 20°c, medicines with penicillins or streptomycins, various nitrogen-based chemicals (138.0 months imported). Regular exporter of various medicines not listed elsewhere, medicines with penicillins or streptomycins, penicillin or streptomycin medicines, various hormone-based medicines, medicines with other antibiotics (36.0 months exported). Operates in the wholesale, the processing & manufacturing, the pharma, the pharma products, the basic pharma, the vaccines, medicaments, diagnostic substances, biotech etc industries.

Aldoori Mohammed Khalid owns this company. The list of owners was changed ten years ago. It is not exhaustive, as only owners with more than twenty five percent of shares are published.

Aldoori Laith Khalid, Aldoori Samie Mohammed, Al-doori Mohammed Khalid are the directors of this company. The list of directors was changed three years ago.

The company was incorporated twenty three years ago on May 01, 2003.

The registration address is RG21 8SR, England, Basingstoke, Hampshire, Key House, Sarum Hill. The address is virtual address as eleven companies registered at the address.

The top import category of the regular importer company is Various medicines not listed elsewhere, Small plastic bottles (under 2 liters), Liquid chemical products at 20°C, Medicines with penicillins or streptomycins, Various nitrogen-based chemicals, imported for 138.0 months. The last import operation was made on April 01, 2026.

The top export category of the regular exporter company is Various medicines not listed elsewhere, Medicines with penicillins or streptomycins, Penicillin or streptomycin medicines, Various hormone-based medicines, Medicines with other antibiotics, exported for 36.0 months. The last export operation was made on April 01, 2026.

The company exports to Algeria, Belgium, China, Hong Kong Special Administrative Region, France, Germany, Ireland, Italy, Japan, and United States. (non-official data, calculated by Corpsignals)

The company imports from Austria, Belgium, China, France, Germany, India, Ireland, Italy, Netherlands, Poland, Singapore, Spain, Switzerland, Turkey, and United States. (non-official data, calculated by Corpsignals)

The company uses the following ports for trade: Birmingham Airport, Dover, East Midlands Airport, Eurotunnel, Felixstowe, Glasgow Airport, Grangemouth Docks, Harwich, Holyhead, Hull, Immingham Docks, Liverpool Docks, London, London Gateway Port, London Heathrow Airport, London Stansted Airport, Manchester Airport, Middlesbrough, Newhaven, and Southampton. (non-official data, calculated by Corpsignals)

The company uses Air transport, Roll on Roll off (RORO), and Sea transport (not vehicle on ferry) for trade. (non-official data, calculated by Corpsignals)

The company operates in the wholesale, the processing & manufacturing, the pharma, the pharma products, the basic pharma, the vaccines, medicaments, diagnostic substances, biotech etc industries.

It's a large company as it met two conditions of three: turnover more than £36 million, balance sheet more than £18 million, employees more than 250. The last reported current assets is £69,892,726, and the revenue is £96,475,385.

CorpSignals sources its data from UK government records including Companies House and HMRC trade data. Data is updated every 24 hours. While we ensure accuracy through automated validation, please refer to original government sources for legal or compliance purposes.